Idiopathic membranous nephropathy: outline and rationale of a treatment strategy.
about
Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndromeMembranous nephropathy: not just a disease for adultsPhosphotriesterase-related protein sensed albuminuria and conferred renal tubular cell activation in membranous nephropathy.Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathySmoking is a risk factor for the progression of idiopathic membranous nephropathy.Controversies in the treatment of idiopathic membranous nephropathy.Resveratrol ameliorates renal damage, increases expression of heme oxygenase-1, and has anti-complement, anti-oxidative, and anti-apoptotic effects in a murine model of membranous nephropathy.Low-molecular-weight proteins as prognostic markers in idiopathic membranous nephropathySynthetic ACTH in High Risk Patients with Idiopathic Membranous Nephropathy: A Prospective, Open Label Cohort Study.Pharmacological treatment of primary membranous nephropathy in 2016.Prognostic value of risk score and urinary markers in idiopathic membranous nephropathy.Treatment of idiopathic membranous nephropathy.Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathyImmunosuppression for membranous nephropathy: a systematic review and meta-analysis of 36 clinical trialsTacrolimus in the treatment of idiopathic nephrotic syndrome.Stepwise treatment using corticosteroids alone and in combination with cyclosporine in korean patients with idiopathic membranous nephropathyMembranous nephropathy: Treatment outline and risk stratificationLatest treatment strategies for membranous nephropathy.Long-term outcomes in idiopathic membranous nephropathy using a restrictive treatment strategyUrinary Volatile Organic Compounds as Potential Biomarkers in Idiopathic Membranous Nephropathy.Treatment of membranous nephropathy: time for a paradigm shift.Chlorambucil-induced cytomegalovirus infection: a case report.Single-dose Rituximab Therapy for Refractory Idiopathic Membranous Nephropathy: A Single-center Experience.Membranous glomerulopathy in an adult patient with X-linked agammaglobulinemia receiving intravenous gammaglobulinA 10-year follow-up of idiopathic membranous nephropathy patients on steroids and cyclophosphamide: a case series.Kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as prognostic markers in idiopathic membranous nephropathy.What is the role of rituximab in idiopathic membranous nephropathy?Introduction of a cyclophosphamide-based treatment strategy and the risk of ESRD in patients with idiopathic membranous nephropathy: a nationwide survey in the Netherlands.Treatment of primary membranous nephropathy: where are we now?Inhibition of tumor necrosis factor signaling attenuates renal immune cell infiltration in experimental membranous nephropathy.Leflunomide plus oral prednisone in treatment of idiopathic membranous nephropathy: a retrospective clinical study of efficacy and safety.Treatment of nephrotic idiopathic membranous nephropathy with monthly i.v. pulse cyclophosphamide and oral steroids: a single centre's retrospective study.
P2860
Q24193098-FF7E2C94-17C7-4727-9F9C-B74E4317062AQ26866206-5D636BC5-DAE6-4007-8DDC-6628B86E6647Q33577283-069B4BF0-EA67-4254-81A5-B3977F38F0C9Q33748541-E37BD65B-D1EE-4124-9A4A-C653D14217D4Q33806897-1BEDBF3D-4798-4535-AA02-920DBDFC9DEFQ34248343-765A89B6-D911-48A9-B527-92C2EFAA81C2Q35587158-DB3F392C-BCE9-4EF0-B56B-868E85C58C1CQ35664611-0CD6EEBC-2184-4EA6-B5E6-9AD585565487Q35840057-0DD8B5DE-6C14-491A-B4EC-BBBD8AE88424Q36106413-1740E97F-3191-4306-A0EE-1B9720841A78Q36126897-4CF67268-224C-4865-B52E-FF86D0DFF0E3Q36280345-52BFF671-1B9A-499F-8054-AF68B2B0419AQ36280364-8C35E4C5-CA8B-4D49-A14A-C37260FABD63Q36810470-FD4C7207-2DAD-4025-866A-CED2AD911B4DQ36861628-AB4E80CC-F9E2-4ABF-A3A6-7247EBE9EC28Q36872799-5F1B61A9-2548-4B9A-A0F8-3422F337366FQ36970147-52098CCC-76F3-4F17-BE18-2821345613ABQ37013035-1794028D-643E-4291-AC74-1F0C7933A55EQ37411651-B38C7FFF-ECCE-48FC-8078-67D5FB39D7FBQ38717036-2E2AA3E9-EB7A-40FB-8E56-02D8AB9CCB4BQ39410091-653DBD8F-93B6-4A1D-A815-B6378783BDADQ40195911-00D548AF-4507-4D5F-9FFF-B853A242E108Q41073990-6A1A8512-0309-42F2-BAF2-B762BD548A33Q41200923-D7751BF5-0FB4-4958-9B02-803B7F3EB3BCQ41541011-84305B46-A3F4-4613-85AF-6EBFD120EBF7Q42155627-222BCEA4-4BF9-4E70-91F3-FFD5727E4558Q45351919-1F64D4C0-1B90-4EFF-830C-ACA8B9D427F6Q46535413-3687E338-4AA6-4091-80E0-EF50E5F5E54DQ47850601-2C0F317C-C13E-4293-B6E5-F24645452E49Q49177794-2CD172F4-036B-4CF5-9A10-BF23EF80AE08Q50788916-EDA58DB0-076D-4400-A5BC-FC498770F7D8Q51742747-DFEEB95C-BBC8-4786-B352-35DC508F2577
P2860
Idiopathic membranous nephropathy: outline and rationale of a treatment strategy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Idiopathic membranous nephropathy: outline and rationale of a treatment strategy.
@ast
Idiopathic membranous nephropathy: outline and rationale of a treatment strategy.
@en
type
label
Idiopathic membranous nephropathy: outline and rationale of a treatment strategy.
@ast
Idiopathic membranous nephropathy: outline and rationale of a treatment strategy.
@en
prefLabel
Idiopathic membranous nephropathy: outline and rationale of a treatment strategy.
@ast
Idiopathic membranous nephropathy: outline and rationale of a treatment strategy.
@en
P2093
P1476
Idiopathic membranous nephropathy: outline and rationale of a treatment strategy.
@en
P2093
Amanda J W Branten
Jack F M Wetzels
Peggy W G du Buf-Vereijken
P304
P356
10.1053/J.AJKD.2005.08.020
P577
2005-12-01T00:00:00Z